Collaboration and in-licensing are becoming increasingly popular within the biotech and pharma industry landscapes, with license agreements serving as the representation of that symbiotic relationship. You may want to view a company’s previous license agreements for business development purposes, competitive intelligence, or simply out of curiosity. The good news is that Biotechgate has you covered in our guide on how to find licensing deals.
About our License Agreements Section
The section contains over 45,000 deals from both large and small companies across the world. We are constantly adding new deals to our database through a screening process combining artificial intelligence and our team of analysts.
There is a variety of criteria to choose from, such as the agreement type, deal size and the year – with our records going back to 1982. You also have the option to choose what Territory you want to search in. This field includes countries, continents as well as geographical groupings (e.g. APAC).
Watch the Walkthrough
Prefer a visual guide? Watch the short walkthrough below to see how to search for licensing deals, apply filters and review agreement details in Biotechgate.
Finding Agreements
Let’s do an example: assume we want to benchmark deals for oncology assets in Phase 1. In the ‘Disease & Clinical Phase’ section, we will select our indication and clinical phase, as shown in the image below.
Date & Territory Agreement
As we are benchmarking, we want recent agreements only. Next, in the ‘Date and Territory Agreement’ section, we will specify the year range as 2022 to present.
Deal Size & Royalties
Under ‘Deal Size & Royalties’, we will only look for deals where the upfront value is less than USD 999 million.
Once you find a result that you are interested in, click on it and you will be given an in-depth look at the license agreement. Here, you can view further information such as a description of the deal, the press release, or the original contract, if available.
Both the licensor and licensee are also shown. Thanks to our collection of over 60,000 companies, the involved parties generally have a profile on our database, letting you view more information about both companies such as their clinical trials, assets and financing rounds.